Anatomical Landmark-guided Suprascapular Nerve Block ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
149Hemiconvulsion hemiplegia epilepsy syndrome1

149. Hemiconvulsion hemiplegia epilepsy syndrome


Clinical trials : 25 Drugs : 40 - (DrugBank : 14) / Drug target genes : 17 - Drug target pathways : 20
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05260125
(ClinicalTrials.gov)
March 15, 202218/2/2022Comparison of the Efficacy of Ultrasound Guided vs Non-guided Suprascapular Nerve Block Treatment in Stroke PatientsComparison of the Efficacy of Ultrasound Guided vs Non-guided Suprascapular Nerve Block Treatment in Stroke Patients With Hemiplegic Shoulder Pain.Hemiplegia;StrokeDrug: Ultrasound-guided Suprascapular Nerve Block;Drug: Anatomical Landmark-guided Suprascapular Nerve BlockAbant Izzet Baysal UniversityNULLNot yet recruiting25 Years75 YearsAll50Phase 4Turkey